arrow
Back
J

Joshua J. Meeks

northwestern university

57H-index
438Paper Count
1.3WCitation Count
Published Papers 180
Publication Date
STING/type I interferon pathway is required for antigen-containing PLGA nanoparticle- and apoptotic cell-induced CD4+T cell tolerance
err2026-01-02
err0
PREAI
errPodojil, Joseph R.; Cogswell, Andrew C.; Neef, Tobias; Chiang, Ming-Yi; Beddow, Sara A.; Arellano, Gabriel; Kakade, Sandeep; McCarthy, Derrick P.; Elhofy, Adam; Harp, Chris T.; Khan, Mairah; Meeks, Joshua J.; Xu, Dan; Shea, Lonnie D.; Miller, Stephen D.
errShare
errSave
STING and IFNalpha/beta receptor are required for antigen-specific apoptotic cell-induced peripheral tolerance
err2025-11-01
err0
PREAI
errPodojil, Joseph R.; Cogswell, Andrew C.; Neef, Tobias; Chiang, Ming-Yi; McCarthy, Derrick P.; Elhofy, Adam; Khan, Mairah; Meeks, Joshua; Miller, Stephen D.
errShare
errSave
Genomic and Transcriptomic Profiling of High-risk Bladder Cancer Reveals Diverse Molecular and Microenvironment Ecosystems
err2025-10-07
err0
PREAI
errKhyati Meghani; Yanni Yu; Noah Frydenlund; Erik Z. Li; Bonnie Choy; Sarki A. Abdulkadir; Joshua J. Meeks
errShare
errSave
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies
err2025-09-10
err0
PREAI
errLexiaochuan Wen; Hiroko Miyagi; Philippe E. Spiess; Alice Yu; Cathy L. Mendelsohn; Wei Shen Tan; Sarah P. Psutka; Seth P. Lerner; Liang Cheng; Lars Dyrskjøt; Joshua J. Meeks; Shahrokh F. Shariat; Paolo Gontero; Benjamin Pradere; Gary D. Steinberg; Ashish M. Kamat; Roger Li
errShare
errSave
Urine-based molecular testing identifies FGFR alteration-positive patients for treatment with TAR-210
err2024-09-01
err0
PREAI
errGuerrero-Ramos, F.; Ku, J. H.; Vilaseca, A.; Raventos, C. X.; Shore, N. D.; Meeks, J.; Li, R.; Daneshmand, S.; Jayram, G.; Kang, T. W.; Beeharry, N.; Zhang, J.; Weingeist, D.; Smirnov, D. A.; Brunton, B.; Cost, C.; Kalota, A.; Lauring, J.; Stone, N.; Thomas, S.
errShare
errSave
A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA)
err2024-09-01
err1
PREAI
errPowles, T. B.; van der Heijden, M. S.; Galsky, M. D.; Al-Ahmadie, H.; Meeks, J. J.; Nishiyama, H.; Vu, T. Q.; Antonuzzo, L.; Wiechno, P.; Atduev, V.; Kann, A. G.; Kim, T-H.; Rodriguez, C. Suarez; Chang, C-H.; Roghmann, F.; Ozguroglu, M.; Armstrong, J.; Ho, S.; Hois, S.; Catto, J.
errShare
errSave
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial (Jun, 10.1038/s41591-024-03025-3, 2024)
err2024-07-02
err1
PREAI
errLi, Roger; Shah, Paras H.; Stewart, Tyler F.; Nam, Jong Kil; Bivalacqua, Trinity J.; Lamm, Donald L.; Uchio, Edward M.; Geynisman, Daniel M.; Jacob, Joseph M.; Meeks, Joshua J.; Dickstein, Rian; Pearce, Shane M.; Kang, Seok Ho; Jung, Seung Il; Kamat, Ashish M.; Burke, James M.; Keegan, Kirk A.; Steinberg, Gary D.
errShare
errSave
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial (Jun, 10.1038/s41591-024-03025-3, 2024)
err2024-06-18
err0
errOAAI
errLi, Roger; Shah, Paras H.; Stewart, Tyler F.; Nam, Jong Kil; Bivalacqua, Trinity J.; Lamm, Donald L.; Uchio, Edward M.; Geynisman, Daniel M.; Jacob, Joseph M.; Meeks, Joshua J.; Dickstein, Rian; Pearce, Shane M.; Kang, Seok Ho; Il Jung, Seung; Kamat, Ashish M.; Burke, James M.; Keegan, Kirk A.; Steinberg, Gary D.
errShare
errSave
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
err2024-06-06
err8
PREAI
errLi, Roger; Shah, Paras H.; Stewart, Tyler F.; Nam, Jong Kil; Bivalacqua, Trinity J.; Lamm, Donald L.; Uchio, Edward M.; Geynisman, Daniel M.; Jacob, Joseph M.; Meeks, Joshua J.; Dickstein, Rian; Pearce, Shane M.; Kang, Seok Ho; Jung, Seung Il; Kamat, Ashish M.; Burke, James M.; Keegan, Kirk A.; Steinberg, Gary D.
errShare
errSave
The Elusive Horizon: Biomarkers in Urothelial Carcinoma
err2024-04-01
err2
PREAI
errLinscott, Joshua A.; Meeks, Joshua J.; Dyrskjot, Lars; Li, Roger
errShare
errSave
Mechanism of action of nadofaragene firadenovec-vncg
err2024-03-15
err5
errOAAI
errNarayan, Vikram M.; Meeks, Joshua J.; Jakobsen, Jorn S.; Shore, Neal D.; Sant, Grannum R.; Konety, Badrinath R.
errShare
errSave
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma
err2024-03-01
err8
PREAI
errHuelster, Heather L.; Gould, Billie; Schiftan, Elizabeth A.; Camperlengo, Lucia; Davaro, Facundo; Rose, Kyle M.; Soupir, Alex C.; Jia, Shidong; Zheng, Tiantian; Sexton, Wade J.; -Sang, Julio Pow; Spiess, Philippe E.; Grass, G. Daniel; Wang, Liang; Wang, Xuefeng; Vosoughi, Aram; Necchi, Andrea; Meeks, Joshua J.; Faltas, Bishoy M.; Du, Pan; Li, Roger
errShare
errSave
Somatic mutations of MLL4/COMPASS induce cytoplasmic localization providing molecular insight into cancer prognosis and treatment
err2023-12-19
err3
errOAAI
errZhao, Zibo; Aoi, Yuki; Philips, Cassandra N.; Meghani, Khyati A.; Gold, Sarah R.; Yu, Yanni; St John, Luke; Qian, Jun; Zeidner, Jacob M.; Meeks, Joshua J.; Shilatifard, Ali
errShare
errSave
Checkpoint Inhibitors in Urothelial Carcinoma-Future Directions and Biomarker Selection
err2023-11-01
err19
errOAAI
errMeeks, Joshua J.; Black, Peter C.; Galsky, Matthew; Grivas, Petros; Hahn, Noah M.; Hussain, Syed A.; Milowsky, Matthew I.; Steinberg, Gary D.; Svatek, Robert S.; Rosenberg, Jonathan E.
errShare
errSave